PolarityTE Announces Appointment of McKesson’s Willie Bogan to Board of Directors
April 24, 2018 08:00 ET
|
PolarityTE, Inc.
SALT LAKE CITY, April 24, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (Nasdaq:COOL), a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of...
“I Would Choose SkinTE Every Time,” says Patient Treated with PolarityTE’s New Skin Regeneration Product
April 18, 2018 08:00 ET
|
PolarityTE, Inc.
SALT LAKE CITY, April 18, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (NASDAQ:COOL) today announced continued success with SkinTE during its limited-market release across a variety of conditions,...
PolarityTE Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriter’s Option
April 16, 2018 10:00 ET
|
PolarityTE, Inc.
SALT LAKE CITY, April 16, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (Nasdaq:COOL), a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of...
PolarityTE Announces Pricing of Public Offering of Common Stock
April 12, 2018 09:15 ET
|
PolarityTE, Inc.
SALT LAKE CITY, April 12, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (Nasdaq:COOL), a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of...
PolarityTE Announces Public Offering of Common Stock
April 11, 2018 16:01 ET
|
PolarityTE, Inc.
SALT LAKE CITY, April 11, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (Nasdaq:COOL), a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of...
PolarityTE™ Provides Business Updates on Clinical Use of SkinTE™: Regeneration of Full-Thickness Skin
February 05, 2018 09:00 ET
|
PolarityTE, Inc.
SALT LAKE CITY, Feb. 05, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (NASDAQ:COOL), today announced that initial results from the clinical applications of the commercially launched SkinTE are yielding...
PolarityTE to Participate in Corporate Access Event in San Francisco, January 8 – 9, 2018
December 21, 2017 08:00 ET
|
PolarityTE, Inc.
SALT LAKE CITY, Dec. 21, 2017 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (NASDAQ:COOL) today announced that its senior management team will host institutional investor and partnering meetings at the...
PolarityTE™ Announces a New 200,000 sq ft Polarity Campus and Corporate Headquarters to Meet the Demand for SkinTE™ and Accelerate Core Technology Platforms into 2018
December 20, 2017 08:30 ET
|
PolarityTE, Inc.
SALT LAKE CITY, Dec. 20, 2017 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (NASDAQ:COOL) today officially announced that the company has continued to expand its R&D and biomedical manufacturing...
PolarityTE™ Announces Application of SkinTE™ on First Patients
December 15, 2017 08:00 ET
|
PolarityTE, Inc.
SALT LAKE CITY, Dec. 15, 2017 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (NASDAQ:COOL) announced that human use of SkinTE™ is underway, and the product is now on patients, at multiple centers, within a...
PolarityTE™ Lead Product, SkinTE™, is Approved for Use by Multiple Medical Institutions
October 19, 2017 08:00 ET
|
PolarityTE, Inc.
SALT LAKE CITY, Oct. 19, 2017 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (NASDAQ:COOL) today announced that multiple value analysis committees have approved SkinTE™ for use at their respective medical...